Clinical and Experimental Hypertension

Clinical and Experimental Hypertension is a reputable journal that has converted to a full Open Access format starting from Volume 45 in 2023. While previous volumes are still accessible through a Pay to Read model, the journal now provides free and open access to its content. It serves as an international platform for the exchange of up-to-date scientific and clinical information concerning both human and animal hypertension. The journal publishes a wide range of articles, including full research papers, solicited and unsolicited reviews, and commentaries. Through these publications, the journal aims to enhance current understanding and support the timely detection, management, control, and prevention of hypertension-related conditions. One notable aspect of Clinical and Experimental Hypertension is its coverage of special issues that focus on the proceedings of symposia dedicated to hypertension research. This feature allows researchers and clinicians to delve deeper into the latest advancements in this field. The journal is abstracted and indexed in several renowned databases, including Pharmacoeconomics and Outcomes News (Online), Reactions Weekly (Online), CABI, EBSCOhost, Elsevier BV, International Atomic Energy Agency, and the National Library of Medicine, among others. These affiliations ensure that the journal's content receives broad visibility and facilitates its discoverability by professionals and researchers in related disciplines.

《临床和实验性高血压》是一本信誉良好的期刊，从2023年第45卷开始已转换为完整的开放获取格式。虽然以前的各卷仍可通过付费阅读模式获取，但该期刊现在提供对其内容的免费和开放获取。它是交流人类和动物高血压最新科学和临床信息的国际平台。该杂志发表了广泛的文章，包括完整的研究论文、征求和主动提供的评论以及评论。通过这些出版物，该杂志旨在增强当前对高血压相关疾病的认识并支持及时发现、管理、控制和预防。